Amanta Healthcare
add_icon

Amanta Healthcare

102.77
-0.04
(-0.04%)
Market Cap
399.05 Cr
PE Ratio
30.60
Volume
17,429.00
Day High - Low
103.80 - 101.54
52W High-Low
154.40 - 97.75
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
399.05 Cr
EPS
3.71
PE Ratio
30.60
PB Ratio
1.93
Book Value
54.26
EBITDA
61.10
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
10.89
Debt to Equity
2.12
Forecast For
Actual

Company News

View All News
Caret
neutral
Amanta Healthcare announces special window for transfer and dematerialisation of physical securities from February 05, 2026 to February 04, 2027 following SEBI circular dated January 30, 2026.
neutral
Amanta Healthcare Limited corrects solar power plant capacity from 10.8 KWp to 10.8 MWp in agreement with Zodiac Energy Limited, re-executing the agreement on January 02, 2026.
positive
Amanta Healthcare utilized Rs 3,030.02 lakhs from its Rs 12,600 lakhs IPO proceeds during the quarter ended September 30, 2025, primarily for capital expenditure on manufacturing equipment and civil construction work. The pharmaceutical company has Rs 9,569.98 lakhs remaining for planned expansion of SteriPort and SVP manufacturing lines at its Gujarat facility, with production expected to commence from January 2026 and 2027 respectively.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,627.90
#1 3,90,587.74
35.27
#1 54,729.00
9.71
#1 10,980
16.07
39.38
5,952.50
1,58,020.17
64.55
9,712.00
18.67
2,191
35.10
34.69
3,987.20
1,34,944.97
63.17
11,539.40
6.99
1,911
30.46
54.84
1,311.60
1,05,947.35
23.63
28,409.50
7.12
5,291
-57.18
23.03
1,182.50
98,695.04
17.87
33,741.20
16.73
5,725
-15.28
40.19
2,129.40
97,270.74
22.48
22,909.50
13.74
3,306
#1 72.75
48.01
879.65
88,513.37
#1 17.58
23,511.00
18.55
4,615
34.60
40.59
2,063.80
85,194.71
48.71
12,744.20
#1 20.90
2,007
-21.05
38.50
1,171.00
68,011.87
19.85
32,345.60
9.43
3,484
3.81
49.49
5,521.50
66,017.81
27.58
13,458.30
3.70
2,216
10.98
36.71

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
-1.95 %
Net Income Growth
191.67 %
Cash Flow Change
-19.72 %
ROE
98.72 %
ROCE
2.63 %
EBITDA Margin (Avg.)
5.99 %

Yearly Financial Results

Annual Financials
2020
2021
2022
2023
2024
2025
TTM
Revenue
187
172
227
263
282
276
278
Expenses
147
133
173
206
223
215
217
EBITDA
40
39
54
56
59
61
61
Operating Profit %
20 %
22 %
23 %
20 %
21 %
22 %
22 %
Depreciation
17
17
17
18
20
18
19
Interest
38
40
49
35
34
28
24
Profit Before Tax
-15
-18
62
3
5
15
19
Tax
4
4
7
5
2
4
7
Net Profit
-19
-22
55
-2
4
11
13
EPS in ₹
-7.04
-8.14
20.54
-0.79
1.35
3.71
4.60

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
2025
Total Assets
388
392
392
374
352
382
Fixed Assets
244
242
240
232
228
217
Current Assets
105
131
136
131
118
138
Capital Work in Progress
0
0
0
9
0
7
Investments
0
2
3
0
4
8
Other Assets
144
149
149
133
120
150
Total Liabilities
388
392
392
374
352
382
Current Liabilities
73
123
106
97
102
115
Non Current Liabilities
285
262
214
214
184
170
Total Equity
29
7
72
63
66
96
Reserve & Surplus
2
-20
36
36
40
68
Share Capital
27
27
37
27
27
29

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
2025
Net Cash Flow
-8
-0
6
-6
1
-1
Investing Activities
-9
-13
-6
-7
-10
-25
Operating Activities
38
31
62
43
58
47
Financing Activities
-37
-18
-50
-42
-46
-24

Share Holding

% Holding
Sept 2024
Feb 2025
Jun 2025
Aug 2025
Sept 2025
Dec 2025
Promoter
85.52 %
85.52 %
63.56 %
85.60 %
63.56 %
63.56 %
FIIs
0.00 %
0.00 %
2.21 %
0.00 %
1.00 %
1.10 %
DIIs
0.00 %
0.00 %
12.22 %
0.00 %
11.34 %
11.24 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
20.28 %
0.00 %
17.35 %
16.91 %
Others
14.48 %
14.48 %
1.74 %
14.40 %
6.75 %
7.19 %
No of Share Holders
192
200
30,695
361
360
16,181

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
26 Sept 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
26 Sept 2025 140.05 139.35
11 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Nov 2025 122.15 120.16

Announcements

Board Meeting Intimation for To Approve Unaudited Financial Results For Quarter Ended December 31 2025.6 hrs ago
Intimation Of Opening Of Special Window For Transfer And Dematerialisation Of Physical Securities.7 hrs ago
Appointment Of Investor Relation (IR) AgencyJan 10, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 07, 2026
Announcement Under Regulation 30Jan 02, 2026
Announcement Under Regulation 30Dec 30, 2025
Closure of Trading WindowDec 29, 2025
Change In CIN Of CompanyNov 29, 2025
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportNov 14, 2025
Re Submission Of Financial Results For Quarter And Half Year Ended September 30 2025.Nov 13, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 13, 2025
Re-Constitution Of Audit CommitteeNov 12, 2025
Statement Of Deviation And VariationNov 11, 2025
To Approve Unaudited Financial Results For Q2 Of FY 2025-26Nov 11, 2025
Board Meeting Outcome for To Approve Unaudited Financial Results For Q2 Of FY 2025-26Nov 11, 2025
Board Meeting Intimation for To Approve Unaudited Financial Results For Quarter Ended September 30 2025Nov 03, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 07, 2025
Intimation Of Change In E-Mail Address Of Registrar And Share Transfer Agent (RTA) Of The CompanyOct 04, 2025
Intimation Of Redemption Of Unlisted 10000000 (One Crore) 14% Non-Convertible Cumulative Participating Redeemable Preference Shares (RPS) Of Face Value Of Rs.10/-Sep 29, 2025
Closure of Trading WindowSep 29, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 27, 2025
Board Meeting Outcome for To Approve Unaudited Financial Result For Q1 Of 2025-26Sep 26, 2025
Result - Financial Results For Q1 Of 2025-26Sep 26, 2025
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations)Sep 26, 2025
Board Meeting Intimation for Inter-Alia To Consider And Approve Unaudited Financial Results Of The Company For The Quarter Ended 30Th June 2025Sep 18, 2025
Closure of Trading WindowSep 12, 2025
Listing of Equity Shares of Amanta Healthcare LtdSep 09, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Bandhan Small Cap Fund Direct-Growth
0.09%
0
0.00%
0.02%

Technical Indicators

RSI(14)
Neutral
44.70
ATR(14)
Less Volatile
4.55
STOCH(9,6)
Neutral
37.27
STOCH RSI(14)
Neutral
59.78
MACD(12,26)
Bearish
-0.08
ADX(14)
Weak Trend
19.04
UO(9)
Bearish
47.95
ROC(12)
Downtrend But Slowing Down
-5.09
WillR(14)
Neutral
-66.59